Table 3.
Association Results of MTRR C524T with Prostate Cancer
| No. and Percentage | OR (95% CI) | χ2 | P-value | ||
|---|---|---|---|---|---|
| Control (n=110) | Case (n=108) | ||||
| Genotype | |||||
| CC | 51 (46.37%) | 35 (32.41%) | - | - | |
| CT | 41 (37.27%) | 54 (50.00%) | 1.92 (1.06 to 3.47) | 4.707 | 0.0308* |
| TT | 18 (16.36%) | 19 (17.59%) | 1.54 (0.71 to 3.34) | 1.192 | 0.2762 |
| CT+TT | 59 (53.64%) | 73 (67.59%) | 1.80 (1.04 to 3.13) | 4.444 | 0.0358* |
| Allele | |||||
| C | 143 (65.00%) | 124 (57.41%) | - | - | |
| T | 77 (35.00%) | 92 (42.59%) | 1.38 (0.94 to 2.03) | 2.647 | 0.1042 |
OR, odds ratio; CI, confidence interval; The significant differences are displayed by*